| Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre (NCT07687186) | Tasly Pharmaceutical Group Co., Ltd | 2026-06-22 |
| A Clinical Trial Evaluating the Efficacy and Safety of Sanhuang Jingshiming Pills in the Treatment of nAMD (NCT07269769) | Tasly Pharmaceutical Group Co., Ltd | 2026-04-30 |
| A Study of the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe Depression (NCT07485595) | Tasly Pharmaceutical Group Co., Ltd | 2026-04-30 |
| TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary Efficacy (NCT07514065) | Tasly Pharmaceutical Group Co., Ltd | 2026-02-20 |
| A Clinical Trial of P134 Cells in Recurrent Glioblastoma (NCT07318818) | Tasly Pharmaceutical Group Co., Ltd | 2026-01-05 |
| A Study of B2065 in Patients With Acute Ischemic Stroke (NCT07371624) | Tasly Pharmaceutical Group Co., Ltd | 2025-12-31 |
| A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure (NCT07265349) | Tasly Pharmaceutical Group Co., Ltd | 2025-12-26 |
| Phase III Trial of Susu Zhike Granules in Children With Cold-cough Syndrome for Acute Cough Treatment (NCT06773117) | Tasly Pharmaceutical Group Co., Ltd | 2025-09-01 |
| A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress Syndrome (NCT06696261) | Tasly Pharmaceutical Group Co., Ltd | 2025-02-27 |
| Efficacy and Safety of Jia Shen Tablets in Chronic Heart Failure (NCT06669169) | Tasly Pharmaceutical Group Co., Ltd | 2025-01-31 |
| Efficacy and Safety of Changkang Granules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver qi Affecting the Spleen Pattern) (NCT06753890) | Tasly Pharmaceutical Group Co., Ltd | 2024-12-30 |
| Efficacy and Safety of Xiangjurupining Capsule for Hyperplasia of Mammary Glands (NCT06685978) | Tasly Pharmaceutical Group Co., Ltd | 2024-04-26 |
| Pharmacokinetic and Pharmacodynamic of Jia Shen Tablets in Chronic Heart Failure (NCT06348498) | Tasly Pharmaceutical Group Co., Ltd | 2024-04-09 |
| A Study of the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe Depression (NCT06259526) | Tasly Pharmaceutical Group Co., Ltd | 2023-12-26 |
| Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis (NCT06058546) | Tasly Pharmaceutical Group Co., Ltd | 2023-11-23 |
| A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common Cold (NCT06697886) | Tasly Pharmaceutical Group Co., Ltd | 2023-11-16 |
| A Study of STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid Tumors (NCT06238687) | Tasly Pharmaceutical Group Co., Ltd | 2023-11-08 |
| A Study to Evaluate Efficacy and Safety of Qingzhu Granules in the Treatment of Acute Gouty Arthritis (NCT06068478) | Tasly Pharmaceutical Group Co., Ltd | 2023-11-07 |
| A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo (NCT06000956) | Tasly Pharmaceutical Group Co., Ltd | 2023-09-11 |
| Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis) (NCT06006689) | Tasly Pharmaceutical Group Co., Ltd | 2023-09-04 |
| HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR) (NCT05632861) | Tasly Pharmaceutical Group Co., Ltd | 2023-02-21 |
| A Study of the Safety,Tolerability,and Pharmacokinetics of Multiple-Ascending Dose JS1-1-01 in Healty Subjects. (NCT05656274) | Tasly Pharmaceutical Group Co., Ltd | 2022-11-29 |
| Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection Fraction (NCT04944706) | Tasly Pharmaceutical Group Co., Ltd | 2021-07-27 |
| Efficacy and Safety of QiShen YiQi Dripping Pills in Chronic Heart Failure (NCT04983043) | Tasly Pharmaceutical Group Co., Ltd | 2021-06-10 |
| A Study of Qishenyiqi Dripping Pills in Healthy Participants (NCT04471298) | Tasly Pharmaceutical Group Co., Ltd | 2020-09-21 |
| Efficacy and Safety of Susu Zhike Granules for Treating Acute Cough Due to Common Cold With Cold-cough Syndrome in Children (NCT04457011) | Tasly Pharmaceutical Group Co., Ltd | 2020-09-19 |
| A Phase Ⅱ Clinical Study of Sanhuangjingshimingwan in Wet( Neovascular)Age-related Macular Degeneration(wAMD) Subjects (NCT04486963) | Tasly Pharmaceutical Group Co., Ltd | 2020-07-24 |
| Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) (NCT04492787) | Tasly Pharmaceutical Group Co., Ltd | 2020-07-06 |
| A Study to Evaluate the Tolerability and Pharmacokinetics of Jiashen Tablets in Healthy Subjects (NCT04164290) | Tasly Pharmaceutical Group Co., Ltd | 2020-06-29 |
| A Study of Xiangjurupining Capsule in the Treatment of Hyperplasia of Breast (Liver Stagnation and Phlegm Coagulation) (NCT04229706) | Tasly Pharmaceutical Group Co., Ltd | 2019-12-31 |
| Study of Jitongning Tablet to Treat Spondyloarthritis (NCT03932019) | Tasly Pharmaceutical Group Co., Ltd | 2019-06-11 |